212 related articles for article (PubMed ID: 33672355)
1. Association of
Woźny Ł; Żywiec J; Gosek K; Kuźniewicz R; Górczyńska-Kosiorz S; Trautsolt W; Śnit M; Grzeszczak W
Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33672355
[TBL] [Abstract][Full Text] [Related]
2. Association of circulating fractalkine (CX3CL1) and CX3CR1(+)CD4(+) T cells with common carotid artery intima-media thickness in patients with chronic kidney disease.
Yadav AK; Lal A; Jha V
J Atheroscler Thromb; 2011; 18(11):958-65. PubMed ID: 21873805
[TBL] [Abstract][Full Text] [Related]
3. Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease?
Cormican S; Griffin MD
Front Immunol; 2021; 12():664202. PubMed ID: 34163473
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of Fractalkine receptor CX3CR1 and plasma levels of its ligand CX3CL1 in colorectal cancer patients.
Dimberg J; Dienus O; Löfgren S; Hugander A; Wågsäter D
Int J Colorectal Dis; 2007 Oct; 22(10):1195-200. PubMed ID: 17611763
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype.
Brand S; Hofbauer K; Dambacher J; Schnitzler F; Staudinger T; Pfennig S; Seiderer J; Tillack C; Konrad A; Göke B; Ochsenkühn T; Lohse P
Am J Gastroenterol; 2006 Jan; 101(1):99-106. PubMed ID: 16405540
[TBL] [Abstract][Full Text] [Related]
6. Association of chemokine receptor CX3CR1 V249I and T280M polymorphisms with chronic kidney disease.
Yadav AK; Kumar V; Jha V
Indian J Nephrol; 2016; 26(4):275-9. PubMed ID: 27512300
[TBL] [Abstract][Full Text] [Related]
7. Fractalkine is a novel human adipochemokine associated with type 2 diabetes.
Shah R; Hinkle CC; Ferguson JF; Mehta NN; Li M; Qu L; Lu Y; Putt ME; Ahima RS; Reilly MP
Diabetes; 2011 May; 60(5):1512-8. PubMed ID: 21525510
[TBL] [Abstract][Full Text] [Related]
8. Two polymorphisms in the Fractalkine receptor CX3CR1 gene influence the development of atherosclerosis: a meta-analysis.
Wu J; Yin RX; Lin QZ; Guo T; Shi GY; Sun JQ; Shen SW; Li Q
Dis Markers; 2014; 2014():913678. PubMed ID: 25221380
[TBL] [Abstract][Full Text] [Related]
9. The chemokine CX3CL1 (fractalkine) and its receptor CX3CR1: occurrence and potential role in osteoarthritis.
Wojdasiewicz P; Poniatowski LA; Kotela A; Deszczyński J; Kotela I; Szukiewicz D
Arch Immunol Ther Exp (Warsz); 2014 Oct; 62(5):395-403. PubMed ID: 24556958
[TBL] [Abstract][Full Text] [Related]
10. CX3CR1 polymorphisms associated with an increased risk of developmental dysplasia of the hip in human.
Li L; Wang X; Zhao Q; Wang E; Wang L; Cheng J; Zhang L; Wang B
J Orthop Res; 2017 Feb; 35(2):377-380. PubMed ID: 27176135
[TBL] [Abstract][Full Text] [Related]
11. Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome. A possible implication of fractalkine in inflammatory activation.
Niessner A; Marculescu R; Haschemi A; Endler G; Zorn G; Weyand CM; Maurer G; Mannhalter C; Wojta J; Wagner O; Huber K
Thromb Haemost; 2005 May; 93(5):949-54. PubMed ID: 15886814
[TBL] [Abstract][Full Text] [Related]
12. CX3CR1 polymorphisms and the risk of age-related macular degeneration.
Ma B; Dang G; Yang S; Duan L; Zhang Y
Int J Clin Exp Pathol; 2015; 8(8):9592-6. PubMed ID: 26464724
[TBL] [Abstract][Full Text] [Related]
13. Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans.
Efsen E; Grappone C; DeFranco RM; Milani S; Romanelli RG; Bonacchi A; Caligiuri A; Failli P; Annunziato F; Pagliai G; Pinzani M; Laffi G; Gentilini P; Marra F
J Hepatol; 2002 Jul; 37(1):39-47. PubMed ID: 12076860
[TBL] [Abstract][Full Text] [Related]
14. Potential biomarkers reflecting inflammation in patients with severe periodontitis: Fractalkine (CX3CL1) and its receptor (CX3CR1).
Balci N; Cekici A; Kurgan Ş; Sahinkaya S; Serdar MA
J Periodontal Res; 2021 Jun; 56(3):589-596. PubMed ID: 33641164
[TBL] [Abstract][Full Text] [Related]
15. Elevated expression of fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) in the dorsal root ganglia and spinal cord in experimental autoimmune encephalomyelitis: implications in multiple sclerosis-induced neuropathic pain.
Zhu W; Acosta C; MacNeil B; Cortes C; Intrater H; Gong Y; Namaka M
Biomed Res Int; 2013; 2013():480702. PubMed ID: 24175290
[TBL] [Abstract][Full Text] [Related]
16. NF-κB-mediated inverse regulation of fractalkine and CX3CR1 during CLP-induced sepsis.
Raspé C; Höcherl K; Rath S; Sauvant C; Bucher M
Cytokine; 2013 Jan; 61(1):97-103. PubMed ID: 23026294
[TBL] [Abstract][Full Text] [Related]
17. CX3CR1 receptor polymorphisms, Th1 cell recruitment, and acute myocardial infarction outcome: looking for a link.
Pucci S; Mazzarelli P; Zonetti MJ; Fisco T; Bonanno E; Spagnoli LG; Mauriello A
Biomed Res Int; 2013; 2013():451349. PubMed ID: 24307998
[TBL] [Abstract][Full Text] [Related]
18. Fractalkine/CX3CR1 is involved in the cross-talk between neuron and glia in neurological diseases.
Luo P; Chu SF; Zhang Z; Xia CY; Chen NH
Brain Res Bull; 2019 Mar; 146():12-21. PubMed ID: 30496784
[TBL] [Abstract][Full Text] [Related]
19. Fractalkine receptor/ligand genetic variants and carotid intima-media thickness.
Debette S; Bevan S; Dartigues JF; Sitzer M; Lorenz M; Ducimetière P; Amouyel P; Markus HS
Stroke; 2009 Jun; 40(6):2212-4. PubMed ID: 19372452
[TBL] [Abstract][Full Text] [Related]
20. CX3CL1-CX3CR1 Axis: A New Player in Coeliac Disease Pathogenesis.
Fernández-Prieto M; Fernández-Aceñero MJ; López-Palacios N; Bodas A; Farrais S; Cuevas D; Pascual V; Cerón-Nieto MÁ; Horta-Herrera S; Espino-Paisán L; Salazar I; Núñez C
Nutrients; 2019 Oct; 11(11):. PubMed ID: 31652730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
